论文部分内容阅读
目的 探讨晚期肝癌介入治疗综合措施 ,进一步提高临床疗效。方法 对 33例肝癌介入治疗晚期综合症状采取一系列治疗措施。 2 1例行经皮股动脉药盒导管系统 (PCS)植入术 ;出血应用凝血酶原复合物 ;肝性脑病应用支链氨基酸和颈精氨酸等综合措施。结果 2 1例PCS术后留置管全部保持通畅。 33例平均生存期 2 0 1个月 ,2年生存率为 36%。结论 对肝癌介入治疗晚期采取一系列综合措施可延长患者生存期 ,提高生存质量 ,是肝癌介入治疗上一个新台阶。
Objective To explore the comprehensive interventional treatment of advanced liver cancer to further improve the clinical efficacy. Methods 33 cases of advanced hepatocellular carcinoma interventional treatment of advanced syndrome to take a series of treatment measures. 21 cases of percutaneous femoral artery catheterization catheterization system (PCS) implantation; bleeding application of prothrombin complex; hepatic encephalopathy using branched chain amino acids and arginine and other comprehensive measures. Results All 21 cases of PCS postoperative indwelling tube remained unobstructed. 33 patients with an average survival of 201 months, 2-year survival rate of 36%. Conclusion A series of comprehensive measures to prolong the survival and improve the quality of life of patients with advanced liver cancer intervention is a new step in the interventional treatment of liver cancer.